The topic of male-orientated birth control has been brought up many times over the past decade. Over 15 years ago, India’s Dr. Sujoy Guha threw around the concept of a hydrogel specifically for male use, though nothing came to fruition – at least not until now. Women have long been subject to annoying and inconsistent fluctuations caused by ‘the pill’, not to mention the various risks associated with it. Unfortunately, alternatives are even less appealing, making the contraceptive pill the best of a bad bunch. And while the trusty condom is still a relatively fail safe method, it seems that its use continues to decline, especially in younger generations. Thankfully however, scientists are currently developing a world-changing product called Vasalgel, which is a male orientated form of contraception that carries zero risk.
In a virtually painless process, a hydrogel is injected into the vas deferens. Its polymer blocks sperm from passing through the tube usually severed during a vasectomy, meaning the man is rendered periodically impotent. The product is currently being tested on male baboons who are now unable to impregnate females, despite having 10 to 15 sexual partners over a six-month period. This consistency of results means human trials will begin sometime over the next 12 months, which means the product could be on the market as early as 2017.